✨
AI Summary
- Capstan Therapeutics CEO Laura Shawver explains in vivo CAR therapies using mRNA and LNP delivery.
- The breakthrough aims to train the patient's body to produce CAR-T cells internally.
- Shawver shares insights on securing funding and investment partnerships for novel therapies.
Guests on This Episode
LS
Laura Shawver
2 podcast appearances